Skip to content

CROI: Vicriviroc appears safe and effective at higher doses in treatment-experienced patients after 48 weeks

CROI: Lactobacillus supplementation could help reduce vaginal HIV

CROI: Recurrent hepatitis C in HIV-positive gay men: relapse or reinfection?

CROI: DAD cohort finds increased risk of heart attack in people taking abacavir or ddI

CROI: Once-daily boosted atazanavir comparable to twice-daily Kaletra in treatment-naive patients, with better lipid profile

CROI: Aciclovir treatment for genital herpes does not reduce HIV acquisition in men or women, major trial shows

CROI: ARV provision in Africa could cut HIV transmission by 90 per cent

CROI: Circumcising HIV positive men may increase HIV infections in female partners, but fewer STIs seen

HIV/hepatitis B coinfection in Africa posing dilemma for 3TC-based ART